ArticleClinics and practice2023

The Efficacy, the Treatment Response and the Aquaretic Effects of a Three-Year Tolvaptan Regimen in Polycystic Kidney Disease Patients.

Vasiliki Gkika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.